Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 4/2020

06.01.2020 | Original Paper

Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level

verfasst von: Xu Dai, Jianhong Deng, Mengmeng Yu, Zhigang Lu, Chengxing Shen, Jiayin Zhang

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

The present study aimed to investigate the association between perivascular fat attenuation index (FAI), high-risk plaque features and serum level of high sensitive C-reactive protein (hs-CRP). Consecutive patients with intermediate pre-test probability of CAD, who were referred for coronary CT angiography (CCTA), were included. High-risk plaque features were assessed by CCTA and included low attenuation plaque (LAP), positive remodeling (PR), napkin-ring sign (NRS) and spotty calcification. Lesion specific perivascular FAI was also measured for all plaques located on major epicardial vessels with diameter ≧ 2 mm. Laboratory test results, including hs-CRP, were recorded. 199 patients with 260 lesions were finally included. NRS and LAP were more commonly present in the group with elevated hs-CRP (35.9% vs. 19.4% and 14.1% vs. 2.6%, both p < 0.05) and more severe stenosis extent was also noted for this group. However, there was no significant difference between the elevated hs-CRP and normal hs-CRP group with respect to other CT parameters, such as lesion length, PR, spotty calcification and focal calcium score. Perivascular FAI failed to show significant difference between the two groups (− 69.8 ± 10.3HU vs. − 70.0 ± 12.0HU, p = 0.953) and there was poor correlation between perivascular FAI and hs-CRP measurements (r =  − 0.04, p = 0.510). In conclusion, LAP and NRS are more commonly present in CAD patients with elevated level of hs-CRP. However, perivascular FAI failed to show such correlation with serum level of hs-CRP.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349:1436–1442CrossRef Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349:1436–1442CrossRef
2.
Zurück zum Zitat Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352(16):1685–1695CrossRef Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352(16):1685–1695CrossRef
3.
Zurück zum Zitat Ekmekci H, Ekmekci OB (2006) The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 12:163–168CrossRef Ekmekci H, Ekmekci OB (2006) The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 12:163–168CrossRef
4.
Zurück zum Zitat Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115–126CrossRef Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115–126CrossRef
5.
Zurück zum Zitat Kubo T, Matsuo Y, Hayashi Y et al (2009) High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study. Coron Artery Dis 20(8):531–535CrossRef Kubo T, Matsuo Y, Hayashi Y et al (2009) High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study. Coron Artery Dis 20(8):531–535CrossRef
6.
Zurück zum Zitat Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195–2207CrossRef Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195–2207CrossRef
7.
Zurück zum Zitat Ridker PM, Cannon CP, Morrow D et al (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352(1):20–28CrossRef Ridker PM, Cannon CP, Morrow D et al (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352(1):20–28CrossRef
8.
Zurück zum Zitat Maurovich-Horvat P, Ferencik M, Voros S, Merkely B, Hoffmann U (2014) Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol 11(7):390–402CrossRef Maurovich-Horvat P, Ferencik M, Voros S, Merkely B, Hoffmann U (2014) Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol 11(7):390–402CrossRef
9.
Zurück zum Zitat Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50:1161–1170CrossRef Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50:1161–1170CrossRef
10.
Zurück zum Zitat Yu M, Li W, Lu Z, Wei M, Yan J, Zhang J (2018) Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis predicts lesion volume progression and long-term prognosis: a serial CT follow-up study. Int J Cardiol. 1(264):181–186CrossRef Yu M, Li W, Lu Z, Wei M, Yan J, Zhang J (2018) Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis predicts lesion volume progression and long-term prognosis: a serial CT follow-up study. Int J Cardiol. 1(264):181–186CrossRef
11.
Zurück zum Zitat Yu M, Lu Z, Li W, Wei M, Yan J, Zhang J (2018) Coronary plaque characteristics on baseline CT predict the need for late revascularization in symptomatic patients after percutaneous intervention. Eur Radiol. 8:3441–3453CrossRef Yu M, Lu Z, Li W, Wei M, Yan J, Zhang J (2018) Coronary plaque characteristics on baseline CT predict the need for late revascularization in symptomatic patients after percutaneous intervention. Eur Radiol. 8:3441–3453CrossRef
12.
Zurück zum Zitat Motoyama S, Sarai M, Harigaya H et al (2009) Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 54(1):49–57CrossRef Motoyama S, Sarai M, Harigaya H et al (2009) Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 54(1):49–57CrossRef
13.
Zurück zum Zitat Antonopoulos AS, Sanna F, Sabharwal N et al (2017) Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med 9:2658CrossRef Antonopoulos AS, Sanna F, Sabharwal N et al (2017) Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med 9:2658CrossRef
14.
Zurück zum Zitat Oikonomou EK, Marwan M, Desai MY et al (2018) Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet 392(10151):929–939CrossRef Oikonomou EK, Marwan M, Desai MY et al (2018) Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet 392(10151):929–939CrossRef
15.
Zurück zum Zitat Yu M, Lu Z, Li W, Wei M, Yan J, Zhang J (2018) CT morphological index provides incremental value to machine learning based CT-FFR for predicting hemodynamically significant coronary stenosis. Int J Cardiol 265:256–261CrossRef Yu M, Lu Z, Li W, Wei M, Yan J, Zhang J (2018) CT morphological index provides incremental value to machine learning based CT-FFR for predicting hemodynamically significant coronary stenosis. Int J Cardiol 265:256–261CrossRef
16.
Zurück zum Zitat Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103(13):1813–1818CrossRef Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103(13):1813–1818CrossRef
17.
Zurück zum Zitat Stenkula KG, Erlanson-Albertsson C (2018) Adipose cell size: importance in health and disease. Am J Physiol Regul Integr Comp Physiol 315(2):R284–R295CrossRef Stenkula KG, Erlanson-Albertsson C (2018) Adipose cell size: importance in health and disease. Am J Physiol Regul Integr Comp Physiol 315(2):R284–R295CrossRef
18.
Zurück zum Zitat Seifarth H, Schlett CL, Nakano M, Otsuka F, Károlyi M, Liew G et al (2012) Histopathological correlates of the napkin-ring sign plaque in coronary CT angiography. Atherosclerosis 224(1):90–96CrossRef Seifarth H, Schlett CL, Nakano M, Otsuka F, Károlyi M, Liew G et al (2012) Histopathological correlates of the napkin-ring sign plaque in coronary CT angiography. Atherosclerosis 224(1):90–96CrossRef
19.
Zurück zum Zitat Motoyama S, Kondo T, Anno H, Sugiura A, Ito Y, Mori K et al (2007) Atherosclerotic plaque characterization by 05-mm-slice multislice computed tomographic imaging. Circ J 71(3):363–366CrossRef Motoyama S, Kondo T, Anno H, Sugiura A, Ito Y, Mori K et al (2007) Atherosclerotic plaque characterization by 05-mm-slice multislice computed tomographic imaging. Circ J 71(3):363–366CrossRef
Metadaten
Titel
Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level
verfasst von
Xu Dai
Jianhong Deng
Mengmeng Yu
Zhigang Lu
Chengxing Shen
Jiayin Zhang
Publikationsdatum
06.01.2020
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 4/2020
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-019-01758-8

Weitere Artikel der Ausgabe 4/2020

The International Journal of Cardiovascular Imaging 4/2020 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.